Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential - Concepedia

Concepedia

Publication | Open Access

Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential

DOI Full Paper Access

106

Citations

32

References

1994

Year

Hiroshi Iino, Masashi Fukayama, Yoshiharu Maeda, Morio Koike, Takeo Mori, Takashi Takahashi, Rei Kikuchi-Yanoshita, Michiko Miyaki, Shoichi Mizuno, Shaw Watanabe

Abstract

The clinical application of molecular genetics (i.e., RFLP analysis of chromosome 17p, 18q, and 22q and RT-PCR analysis of DCC expression into messenger RNA) can be used to determine the metastatic potential of colorectal carcinomas.

References

	Year	Citations

Page 1